Alterations of gut and oral microbiome in Alzheimer's disease

Alterations of gut and oral microbiome in Alzheimer's disease - ADMB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031234

Enrollment

300

Registered

2023-03-10

Start date

2018-09-03

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G30

Interventions

Group 1: Stool and saliva samples of Patients with Alzheimers disease (AD) and mild cognitive impairment (MCI), a risk group (APOE4 carriers) and healthy controls

Eligibility

Sex/Gender

All

Age

45 Years to No maximum

Inclusion criteria

Inclusion criteria: Assignment to one of the groups: AD, MCI, risk, healthy controls

Exclusion criteria

Exclusion criteria: further neurological disease diagnosed (e.g. Parkinson's disease, epileptic seisures, stroke, major depression)

Design outcomes

Primary

Measure	Time frame
Characterization of the gut an oral microbiome of Patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI), a risk group (APOE4 carriers) and healthy controls	—

Secondary

Measure	Time frame
disease specific marker	—

Countries

Germany

Contacts

Public ContactThorsten Bartsch

Klinik für Neurologie, UKSH Campus Kiel

t.bartsch@neurologie.uni-kiel.de043150023842

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026